{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:43:05Z","timestamp":1790808185624,"version":"4.1.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T00:00:00Z","timestamp":1666742400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T00:00:00Z","timestamp":1666742400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000069","name":"U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["AR42309"],"award-info":[{"award-number":["AR42309"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In addition to autoimmune and inflammatory diseases, variants of the TNFAIP3 gene encoding the ubiquitin-editing enzyme A20 are also associated with fibrosis in systemic sclerosis (SSc). However, it remains unclear how genetic factors contribute to SSc pathogenesis, and which cell types drive the disease due to SSc-specific genetic alterations. We therefore characterize the expression, function, and role of A20, and its negative transcriptional regulator DREAM, in patients with SSc and disease models. Levels of A20 are significantly reduced in SSc skin and lungs, while DREAM is elevated. In isolated fibroblasts, A20 mitigates ex vivo profibrotic responses. Mice haploinsufficient for A20, or harboring fibroblasts-specific A20 deletion, recapitulate major pathological features of SSc, whereas DREAM-null mice with elevated A20 expression are protected. In DREAM-null fibroblasts, TGF-\u03b2 induces the expression of A20, compared to wild-type fibroblasts. An anti-fibrotic small molecule targeting cellular adiponectin receptors stimulates A20 expression in vitro in wild-type but not A20-deficient fibroblasts and in bleomycin-treated mice. Thus, A20 has a novel cell-intrinsic function in restraining fibroblast activation, and together with DREAM, constitutes a critical regulatory network governing the fibrotic process in SSc. A20 and DREAM represent novel druggable targets for fibrosis therapy.<\/jats:p>","DOI":"10.1038\/s41467-022-33767-y","type":"journal-article","created":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T13:09:20Z","timestamp":1666789760000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Fibroblast A20 governs fibrosis susceptibility and its repression by DREAM promotes fibrosis in multiple organs"],"prefix":"10.1038","volume":"13","author":[{"given":"Wenxia","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swarna","family":"Bale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bharath","family":"Yalavarthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dibyendu","family":"Bhattacharyya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing Jing","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiam","family":"Abdala-Valencia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanshi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta G.","family":"Marangoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Herzog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergejs","family":"Berdnikovs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9556-0718","authenticated-orcid":false,"given":"Stephen D.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amr H.","family":"Sawalha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7149-9115","authenticated-orcid":false,"given":"Pei-Suen","family":"Tsou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3864-5587","authenticated-orcid":false,"given":"Kentaro","family":"Awaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihide","family":"Asano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chinnaswamy","family":"Tiruppathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjana","family":"Yeldandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1433-0188","authenticated-orcid":false,"given":"Bettina C.","family":"Schock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swati","family":"Bhattacharyya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Varga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,26]]},"reference":[{"key":"33767_CR1","doi-asserted-by":"publisher","first-page":"15002","DOI":"10.1038\/nrdp.2015.2","volume":"1","author":"Y Allanore","year":"2015","unstructured":"Allanore, Y. et al. Systemic sclerosis. Nat. Rev. Dis. Prim. 1, 15002 (2015).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"33767_CR2","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","volume":"390","author":"CP Denton","year":"2017","unstructured":"Denton, C. P. & Khanna, D. Systemic sclerosis. Lancet 390, 1685\u20131699 (2017).","journal-title":"Lancet"},{"key":"33767_CR3","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/nrrheum.2011.149","volume":"8","author":"S Bhattacharyya","year":"2011","unstructured":"Bhattacharyya, S., Wei, J. & Varga, J. Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities. Nat. Rev. Rheumatol. 8, 42\u201354 (2011).","journal-title":"Nat. Rev. Rheumatol."},{"key":"33767_CR4","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/s41584-019-0322-7","volume":"15","author":"JHW Distler","year":"2019","unstructured":"Distler, J. H. W. et al. Shared and distinct mechanisms of fibrosis. Nat. Rev. Rheumatol. 15, 705\u2013730 (2019).","journal-title":"Nat. Rev. Rheumatol."},{"key":"33767_CR5","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1136\/annrheumdis-2016-210645","volume":"76","author":"C Terao","year":"2017","unstructured":"Terao, C. et al. Transethnic meta-analysis identifies GSDMA and PRDM1 as susceptibility genes to systemic sclerosis. Ann. Rheum. Dis. 76, 1150\u20131158 (2017).","journal-title":"Ann. Rheum. Dis."},{"key":"33767_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12760-y","volume":"10","author":"E Lopez-Isac","year":"2019","unstructured":"Lopez-Isac, E. et al. GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways. Nat. Commun. 10, 4955 (2019).","journal-title":"Nat. Commun."},{"key":"33767_CR7","doi-asserted-by":"publisher","first-page":"103914","DOI":"10.1016\/j.cellimm.2019.04.002","volume":"340","author":"BA Malynn","year":"2019","unstructured":"Malynn, B. A. & Ma, A. A20: a multifunctional tool for regulating immunity and preventing disease. Cell Immunol. 340, 103914 (2019).","journal-title":"Cell Immunol."},{"key":"33767_CR8","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1038\/cdd.2011.55","volume":"18","author":"S Lippens","year":"2011","unstructured":"Lippens, S. et al. Keratinocyte-specific ablation of the NF-kappaB regulatory protein A20 (TNFAIP3) reveals a role in the control of epidermal homeostasis. Cell Death Differ. 18, 1845\u20131853 (2011).","journal-title":"Cell Death Differ."},{"key":"33767_CR9","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3934\/Allergy.2021009","volume":"5","author":"S Bale","year":"2021","unstructured":"Bale, S., Varga, J. & Bhattacharyya, S. Role of RP105 and A20 in negative regulation of toll-like receptor activity in fibrosis: potential targets for therapeutic intervention. Aims Allergy Immunol. 5, 102\u2013126 (2021).","journal-title":"Aims Allergy Immunol."},{"key":"33767_CR10","doi-asserted-by":"publisher","first-page":"e0114017","DOI":"10.1371\/journal.pone.0114017","volume":"10","author":"ME Johnson","year":"2015","unstructured":"Johnson, M. E. et al. Experimentally-derived fibroblast gene signatures identify molecular pathways associated with distinct subsets of systemic sclerosis patients in three independent cohorts. PLoS One 10, e0114017 (2015).","journal-title":"PLoS One"},{"key":"33767_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-41153-w","volume":"9","author":"L Chadli","year":"2019","unstructured":"Chadli, L. et al. Identification of regulators of the myofibroblast phenotype of primary dermal fibroblasts from early diffuse systemic sclerosis patients. Sci. Rep. 9, 4521 (2019).","journal-title":"Sci. Rep."},{"key":"33767_CR12","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1002\/art.38288","volume":"66","author":"RB Christmann","year":"2014","unstructured":"Christmann, R. B. et al. Association of Interferon- and transforming growth factor beta-regulated genes and macrophage activation with systemic sclerosis-related progressive lung fibrosis. Arthritis Rheumatol. 66, 714\u2013725 (2014).","journal-title":"Arthritis Rheumatol."},{"key":"33767_CR13","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/1465-9921-14-80","volume":"14","author":"GE Lindahl","year":"2013","unstructured":"Lindahl, G. E. et al. Microarray profiling reveals suppressed interferon stimulated gene program in fibroblasts from scleroderma-associated interstitial lung disease. Respir. Res. 14, 80 (2013).","journal-title":"Respir. Res."},{"key":"33767_CR14","doi-asserted-by":"publisher","first-page":"e0180481","DOI":"10.1371\/journal.pone.0180481","volume":"12","author":"A Aki","year":"2017","unstructured":"Aki, A., Nagasaki, M., Malynn, B. A., Ma, A. & Kagari, T. Hypomorphic A20 expression confers susceptibility to psoriasis. PLoS One 12, e0180481 (2017).","journal-title":"PLoS One"},{"key":"33767_CR15","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1126\/science.289.5488.2350","volume":"289","author":"EG Lee","year":"2000","unstructured":"Lee, E. G. et al. Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice. Science 289, 2350\u20132354 (2000).","journal-title":"Science"},{"key":"33767_CR16","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1002\/art.39658","volume":"68","author":"JL Sargent","year":"2016","unstructured":"Sargent, J. L. et al. Identification of optimal mouse models of systemic sclerosis by interspecies comparative genomics. Arthritis Rheumatol. 68, 2003\u20132015 (2016).","journal-title":"Arthritis Rheumatol."},{"key":"33767_CR17","doi-asserted-by":"publisher","first-page":"436053","DOI":"10.1155\/2013\/436053","volume":"2013","author":"J Manne","year":"2013","unstructured":"Manne, J., Markova, M., Siracusa, L. D. & Jimenez, S. A. Collagen content in skin and internal organs of the tight skin mouse: an animal model of scleroderma. Biochem. Res. Int. 2013, 436053 (2013).","journal-title":"Biochem. Res. Int."},{"key":"33767_CR18","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1101\/gr.6.4.300","volume":"6","author":"LD Siracusa","year":"1996","unstructured":"Siracusa, L. D. et al. A tandem duplication within the fibrillin 1 gene is associated with the mouse tight skin mutation. Genome Res. 6, 300\u2013313 (1996).","journal-title":"Genome Res."},{"key":"33767_CR19","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1002\/art.34424","volume":"64","author":"J Wei","year":"2012","unstructured":"Wei, J. et al. Wnt\/beta-catenin signaling is hyperactivated in systemic sclerosis and induces Smad-dependent fibrotic responses in mesenchymal cells. Arthritis Rheum. 64, 2734\u20132745 (2012).","journal-title":"Arthritis Rheum."},{"key":"33767_CR20","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1002\/art.30312","volume":"63","author":"J Wei","year":"2011","unstructured":"Wei, J. et al. Canonical Wnt signaling induces skin fibrosis and subcutaneous lipoatrophy: a novel mouse model for scleroderma? Arthritis Rheum. 63, 1707\u20131717 (2011).","journal-title":"Arthritis Rheum."},{"key":"33767_CR21","doi-asserted-by":"publisher","first-page":"e0229445","DOI":"10.1371\/journal.pone.0229445","volume":"15","author":"M Zhang","year":"2020","unstructured":"Zhang, M. et al. Targeting the Wnt signaling pathway through R-spondin 3 identifies an anti-fibrosis treatment strategy for multiple organs. PLoS One 15, e0229445 (2020).","journal-title":"PLoS One"},{"key":"33767_CR22","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1111\/exd.12255","volume":"22","author":"C Dees","year":"2013","unstructured":"Dees, C. & Distler, J. H. Canonical Wnt signalling as a key regulator of fibrogenesis \u2013 implications for targeted therapies? Exp. Dermatol. 22, 710\u2013713 (2013).","journal-title":"Exp. Dermatol."},{"key":"33767_CR23","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1136\/annrheumdis-2012-202275","volume":"72","author":"A Distler","year":"2013","unstructured":"Distler, A. et al. Inactivation of tankyrases reduces experimental fibrosis by inhibiting canonical Wnt signalling. Ann. Rheum. Dis. 72, 1575\u20131580 (2013).","journal-title":"Ann. Rheum. Dis."},{"key":"33767_CR24","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1136\/annrheumdis-2011-200568","volume":"71","author":"C Beyer","year":"2012","unstructured":"Beyer, C. et al. beta-catenin is a central mediator of pro-fibrotic Wnt signaling in systemic sclerosis. Ann. Rheum. Dis. 71, 761\u2013767 (2012).","journal-title":"Ann. Rheum. Dis."},{"key":"33767_CR25","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1016\/j.jid.2017.06.032","volume":"137","author":"R Lafyatis","year":"2017","unstructured":"Lafyatis, R. et al. Inhibition of beta-catenin signaling in the skin rescues cutaneous adipogenesis in systemic sclerosis: a randomized, double-blind, placebo-controlled trial of C-82. J. Invest. Dermatol. 137, 2473\u20132483 (2017).","journal-title":"J. Invest. Dermatol."},{"key":"33767_CR26","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/nm.2574","volume":"18","author":"VW Wong","year":"2011","unstructured":"Wong, V. W. et al. Focal adhesion kinase links mechanical force to skin fibrosis via inflammatory signaling. Nat. Med. 18, 148\u2013152 (2011).","journal-title":"Nat. Med."},{"key":"33767_CR27","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1002\/art.33482","volume":"64","author":"D Lagares","year":"2012","unstructured":"Lagares, D. et al. Inhibition of focal adhesion kinase prevents experimental lung fibrosis and myofibroblast formation. Arthritis Rheum. 64, 1653\u20131664 (2012).","journal-title":"Arthritis Rheum."},{"key":"33767_CR28","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1111\/j.0022-202X.2005.23701.x","volume":"124","author":"Y Mimura","year":"2005","unstructured":"Mimura, Y. et al. Constitutive phosphorylation of focal adhesion kinase is involved in the myofibroblast differentiation of scleroderma fibroblasts. J. Invest. Dermatol. 124, 886\u2013892 (2005).","journal-title":"J. Invest. Dermatol."},{"key":"33767_CR29","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1093\/rheumatology\/kes234","volume":"51","author":"X Shi-wen","year":"2012","unstructured":"Shi-wen, X. et al. Focal adhesion kinase and reactive oxygen species contribute to the persistent fibrotic phenotype of lesional scleroderma fibroblasts. Rheumatology (Oxford) 51, 2146\u20132154 (2012).","journal-title":"Rheumatology (Oxford)"},{"key":"33767_CR30","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/imr.12302","volume":"266","author":"MC Walsh","year":"2015","unstructured":"Walsh, M. C., Lee, J. & Choi, Y. Tumor necrosis factor receptor-associated factor 6 (TRAF6) regulation of development, function, and homeostasis of the immune system. Immunol. Rev. 266, 72\u201392 (2015).","journal-title":"Immunol. Rev."},{"key":"33767_CR31","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1126\/science.1182364","volume":"327","author":"N Shembade","year":"2010","unstructured":"Shembade, N., Ma, A. & Harhaj, E. W. Inhibition of NF-kappaB signaling by A20 through disruption of ubiquitin enzyme complexes. Science 327, 1135\u20131139 (2010).","journal-title":"Science"},{"key":"33767_CR32","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0092-8674(01)00629-8","volume":"108","author":"HY Cheng","year":"2002","unstructured":"Cheng, H. Y. et al. DREAM is a critical transcriptional repressor for pain modulation. Cell 108, 31\u201343 (2002).","journal-title":"Cell"},{"key":"33767_CR33","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/ni.2823","volume":"15","author":"C Tiruppathi","year":"2014","unstructured":"Tiruppathi, C. et al. The transcription factor DREAM represses the deubiquitinase A20 and mediates inflammation. Nat. Immunol. 15, 239\u2013247 (2014).","journal-title":"Nat. Immunol."},{"key":"33767_CR34","doi-asserted-by":"publisher","first-page":"L456","DOI":"10.1152\/ajplung.00335.2018","volume":"316","author":"G Momtazi","year":"2019","unstructured":"Momtazi, G., Lambrecht, B. N., Naranjo, J. R. & Schock, B. C. Regulators of A20 (TNFAIP3): new drug-able targets in inflammation. Am. J. Physiol. Lung Cell Mol. Physiol. 316, L456\u2013L469 (2019).","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"33767_CR35","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1080\/15592294.2018.1469891","volume":"13","author":"L Handoko","year":"2018","unstructured":"Handoko, L. et al. JQ1 affects BRD2-dependent and independent transcription regulation without disrupting H4-hyperacetylated chromatin states. Epigenetics 13, 410\u2013431 (2018).","journal-title":"Epigenetics"},{"key":"33767_CR36","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1172\/JCI82670","volume":"126","author":"JR Naranjo","year":"2016","unstructured":"Naranjo, J. R. et al. Activating transcription factor 6 derepression mediates neuroprotection in Huntington disease. J. Clin. Invest. 126, 627\u2013638 (2016).","journal-title":"J. Clin. Invest."},{"key":"33767_CR37","doi-asserted-by":"publisher","first-page":"449","DOI":"10.3389\/fnmol.2018.00449","volume":"11","author":"R Naranjo","year":"2018","unstructured":"Naranjo, R. et al. Inhibition of the neuronal calcium sensor DREAM modulates presenilin-2 endoproteolysis. Front. Mol. Neurosci. 11, 449 (2018).","journal-title":"Front. Mol. Neurosci."},{"key":"33767_CR38","doi-asserted-by":"publisher","first-page":"R229","DOI":"10.1186\/ar4070","volume":"14","author":"F Fang","year":"2012","unstructured":"Fang, F. et al. The adipokine adiponectin has potent anti-fibrotic effects mediated via adenosine monophosphate-activated protein kinase: novel target for fibrosis therapy. Arthritis Res. Ther. 14, R229 (2012).","journal-title":"Arthritis Res. Ther."},{"key":"33767_CR39","doi-asserted-by":"publisher","first-page":"R102","DOI":"10.1186\/ar3827","volume":"14","author":"K Lakota","year":"2012","unstructured":"Lakota, K. et al. Levels of adiponectin, a marker for PPAR-gamma activity, correlate with skin fibrosis in systemic sclerosis: potential utility as biomarker? Arthritis Res. Ther. 14, R102 (2012).","journal-title":"Arthritis Res. Ther."},{"key":"33767_CR40","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nature12656","volume":"503","author":"M Okada-Iwabu","year":"2013","unstructured":"Okada-Iwabu, M. et al. A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity. Nature 503, 493\u2013499 (2013).","journal-title":"Nature"},{"key":"33767_CR41","doi-asserted-by":"publisher","first-page":"94","DOI":"10.2174\/1874467212666191022102800","volume":"13","author":"I Ahmad Bhat","year":"2020","unstructured":"Ahmad Bhat, I. et al. AdipoRon: a novel insulin sensitizer in various complications and the underlying mechanisms: a review. Curr. Mol. Pharm. 13, 94\u2013107 (2020).","journal-title":"Curr. Mol. Pharm."},{"key":"33767_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-04162-1","volume":"7","author":"RG Marangoni","year":"2017","unstructured":"Marangoni, R. G. et al. Adiponectin is an endogenous anti-fibrotic mediator and therapeutic target. Sci. Rep. 7, 4397 (2017).","journal-title":"Sci. Rep."},{"key":"33767_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-29901-w","volume":"8","author":"T Yamashita","year":"2018","unstructured":"Yamashita, T. et al. An orally-active adiponectin receptor agonist mitigates cutaneous fibrosis, inflammation and microvascular pathology in a murine model of systemic sclerosis. Sci. Rep. 8, 11843 (2018).","journal-title":"Sci. Rep."},{"key":"33767_CR44","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s13075-016-1118-7","volume":"18","author":"S Bhattacharyya","year":"2016","unstructured":"Bhattacharyya, S., Wang, W., Graham, L. V. & Varga, J. A20 suppresses canonical Smad-dependent fibroblast activation: novel function for an endogenous inflammatory modulator. Arthritis Res. Ther. 18, 216 (2016).","journal-title":"Arthritis Res. Ther."},{"key":"33767_CR45","doi-asserted-by":"publisher","first-page":"e62223","DOI":"10.1371\/journal.pone.0062223","volume":"8","author":"L Shao","year":"2013","unstructured":"Shao, L. et al. A20 restricts wnt signaling in intestinal epithelial cells and suppresses colon carcinogenesis. PLoS One 8, e62223 (2013).","journal-title":"PLoS One"},{"key":"33767_CR46","doi-asserted-by":"publisher","first-page":"e0195893","DOI":"10.1371\/journal.pone.0195893","volume":"13","author":"BN Nakamura","year":"2018","unstructured":"Nakamura, B. N. et al. A20 regulates canonical wnt-signaling through an interaction with RIPK4. PLoS One 13, e0195893 (2018).","journal-title":"PLoS One"},{"key":"33767_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms1734","volume":"3","author":"A Akhmetshina","year":"2012","unstructured":"Akhmetshina, A. et al. Activation of canonical Wnt signalling is required for TGF-beta-mediated fibrosis. Nat. Commun. 3, 735 (2012).","journal-title":"Nat. Commun."},{"key":"33767_CR48","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.immuni.2010.07.017","volume":"33","author":"RM Tavares","year":"2010","unstructured":"Tavares, R. M. et al. The ubiquitin modifying enzyme A20 restricts B cell survival and prevents autoimmunity. Immunity 33, 181\u2013191 (2010).","journal-title":"Immunity"},{"key":"33767_CR49","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1111\/liv.14935","volume":"41","author":"S Deshayes","year":"2021","unstructured":"Deshayes, S. et al. Chronic hepatic involvement in the clinical spectrum of A20 haploinsufficiency. Liver Int. 41, 1894\u20131900 (2021).","journal-title":"Liver Int."},{"key":"33767_CR50","doi-asserted-by":"crossref","unstructured":"Asano, Y. The pathogenesis of systemic sclerosis: an understanding based on a common pathologic cascade across multiple organs and additional organ-specific pathologies. J. Clin. Med. 9, 2687 (2020).","DOI":"10.3390\/jcm9092687"},{"key":"33767_CR51","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.1002\/art.34490","volume":"64","author":"E Koumakis","year":"2012","unstructured":"Koumakis, E. et al. Brief report: candidate gene study in systemic sclerosis identifies a rare and functional variant of the TNFAIP3 locus as a risk factor for polyautoimmunity. Arthritis Rheum. 64, 2746\u20132752 (2012).","journal-title":"Arthritis Rheum."},{"key":"33767_CR52","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1002\/art.41694","volume":"73","author":"PS Tsou","year":"2021","unstructured":"Tsou, P. S., Palisoc, P. J., Ali, M., Khanna, D. & Sawalha, A. H. Genome-wide reduction in chromatin accessibility and unique transcription factor footprints in endothelial cells and fibroblasts in scleroderma skin. Arthritis Rheumatol. 73, 1501\u20131513 (2021).","journal-title":"Arthritis Rheumatol."},{"key":"33767_CR53","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/nature02794","volume":"430","author":"IE Wertz","year":"2004","unstructured":"Wertz, I. E. et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature 430, 694\u2013699 (2004).","journal-title":"Nature"},{"key":"33767_CR54","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1681\/ASN.2017060627","volume":"29","author":"Y Kim","year":"2018","unstructured":"Kim, Y. et al. The adiponectin receptor agonist AdipoRon ameliorates diabetic nephropathy in a model of type 2 diabetes. J. Am. Soc. Nephrol. 29, 1108\u20131127 (2018).","journal-title":"J. Am. Soc. Nephrol."},{"key":"33767_CR55","doi-asserted-by":"publisher","first-page":"126","DOI":"10.4049\/jimmunol.1403149","volume":"195","author":"Y Wang","year":"2015","unstructured":"Wang, Y., Park, N. Y., Jang, Y., Ma, A. & Jiang, Q. Vitamin E gamma-tocotrienol inhibits cytokine-stimulated NF-kappaB activation by induction of anti-inflammatory A20 via stress adaptive response due to modulation of sphingolipids. J. Immunol. 195, 126\u2013133 (2015).","journal-title":"J. Immunol."},{"key":"33767_CR56","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1136\/annrheumdis-2017-212537","volume":"77","author":"C Municio","year":"2018","unstructured":"Municio, C. et al. Methotrexate limits inflammation through an A20-dependent cross-tolerance mechanism. Ann. Rheum. Dis. 77, 752\u2013759 (2018).","journal-title":"Ann. Rheum. Dis."},{"key":"33767_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11703","volume":"7","author":"S Bhattacharyya","year":"2016","unstructured":"Bhattacharyya, S. et al. Tenascin-C drives persistence of organ fibrosis. Nat. Commun. 7, 11703 (2016).","journal-title":"Nat. Commun."},{"key":"33767_CR58","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1038\/cdd.2015.52","volume":"22","author":"P Studer","year":"2015","unstructured":"Studer, P. et al. Significant lethality following liver resection in A20 heterozygous knockout mice uncovers a key role for A20 in liver regeneration. Cell Death Differ. 22, 2068\u20132077 (2015).","journal-title":"Cell Death Differ."},{"key":"33767_CR59","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.gpb.2015.09.001","volume":"13","author":"H Zhu","year":"2015","unstructured":"Zhu, H., Luo, H., Yan, M., Zuo, X. & Li, Q. Z. Autoantigen microarray for high-throughput autoantibody profiling in systemic lupus erythematosus. Genomics Proteom. Bioinforma. 13, 210\u2013218 (2015).","journal-title":"Genomics Proteom. Bioinforma."},{"key":"33767_CR60","doi-asserted-by":"crossref","unstructured":"Bhattacharyya, S. et al. TLR4-dependent fibroblast activation drives persistent organ fibrosis in skin and lung. JCI Insight 3, e98850 (2018).","DOI":"10.1172\/jci.insight.98850"},{"key":"33767_CR61","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ajpath.2012.09.007","volume":"182","author":"S Bhattacharyya","year":"2013","unstructured":"Bhattacharyya, S. et al. Toll-like receptor 4 signaling augments transforming growth factor-beta responses: a novel mechanism for maintaining and amplifying fibrosis in scleroderma. Am. J. Pathol. 182, 192\u2013205 (2013).","journal-title":"Am. J. Pathol."},{"key":"33767_CR62","doi-asserted-by":"publisher","first-page":"232ra250","DOI":"10.1126\/scitranslmed.3008264","volume":"6","author":"S Bhattacharyya","year":"2014","unstructured":"Bhattacharyya, S. et al. FibronectinEDA promotes chronic cutaneous fibrosis through Toll-like receptor signaling. Sci. Transl. Med. 6, 232ra250 (2014).","journal-title":"Sci. Transl. Med."}],"updated-by":[{"DOI":"10.1038\/s41467-023-36285-7","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T00:00:00Z","timestamp":1675123200000}}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-33767-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-33767-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-33767-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T16:12:51Z","timestamp":1675354371000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-33767-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,26]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["33767"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-33767-y","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41467-023-36285-7","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,26]]},"assertion":[{"value":"18 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41467-023-36285-7","URL":"https:\/\/doi.org\/10.1038\/s41467-023-36285-7","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6358"}}